This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Retrospective analysis of the clinical features of 172 patients with BCR-ABL1-negative chronic myeloproliferative neoplasms
Molecular Cytogenetics Open Access 17 February 2020
-
Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation
Experimental Hematology & Oncology Open Access 30 April 2019
-
A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies
Leukemia Open Access 23 July 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kaushansky K . On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. Blood 2005; 105: 4187–4190.
Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061.
James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148.
Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7: 387–397.
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779–1790.
Kralovics R, Guan Y, Prchal JT . Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol 2002; 30: 229–236.
Imbert M, Pierre R, Thiele J, Vardiman JW, Brunning RD, Flandrin G . Essential thrombocythaemia. In: Jaffe ES, Harris NL, Stein H et al (eds). WHO Classification of Tumors: Tumors of Hematopoietic and Lymphois Tissues. Lyon: IARC Press, 2001, pp 39–41.
Vannucchi AM, Grossi A, Pancrazzi A, Antonioli E, Guglielmelli P, Balestri F et al. PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia. Br J Haematol 2004; 127: 214–219.
Acknowledgements
This study was supported by the Italian Ministry of Health (Progetti di Ricerca di Interesse Nazionale 2003, #06488803); funds from the University of Florence (ex-60%), Associazione Italiana per la Ricerca sul Cancro, Milano, and Ente Cassa di Risparmio di Firenze. AP was the recipient of a fellowship from Associazione Italiana per le Leucemie, Firenze.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Antonioli, E., Guglielmelli, P., Pancrazzi, A. et al. Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. Leukemia 19, 1847–1849 (2005). https://doi.org/10.1038/sj.leu.2403902
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403902
This article is cited by
-
IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia
Frontiers of Medicine (2022)
-
Retrospective analysis of the clinical features of 172 patients with BCR-ABL1-negative chronic myeloproliferative neoplasms
Molecular Cytogenetics (2020)
-
Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation
Experimental Hematology & Oncology (2019)
-
Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms
Journal of Thrombosis and Thrombolysis (2018)
-
Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era
Leukemia (2017)